Same Indication

Ipilimumab vs Pravastatin

Ipilimumab vs Pravastatin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Pravastatin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pravastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Pravastatin β€” 1.8 hours.

Chemical Properties

Molecular Formula: Pravastatin β€” C23H36O7.

Molecular Weight: Pravastatin β€” 424.5280 g/mol.

Type: Ipilimumab β€” Antibody; Pravastatin β€” Small molecule.